检索结果-南通市图书馆

Accuracy of combined PET/CT in image-guided interventions of liver lesions: An ex-vivo study

World Journal of Gastroenterology 2006年第15期12卷 2388-2393页

作者： Patrick Veit Christiane Kuehle Thomas Beyer Hilmar Kuehl Andreas Bockisch gerald antoch Department of Diagnostic and Interventional Radiology and Neuroradiology Department of Nuclear Medicine University Hospital Essen

AIM： Positioning of interventional devices in liver lesions is a challenging task if only CT is available. We investigated the potential benefit of combined PET/CT images for localization of interventional devices in interventional liver studies. METHODS： Thirty lesions each of hyperdense, isodense and hypodense attenuation compared to normal liver parenchyma were injected into 15 ex-vivo pig livers. All lesions were composed of the same amounts of gelatine containing 0.5 MBq of ^18F-FDG. Following lesion insertion, an interventional needle was placed in each lesion under CT-guidance solely. After that, a PET/CT study was performed. The localization of the needle within the lesion was assessed for CT alone and PET/CT and the root mean square （RMS） was calculated. Results were compared with macroscopic measurements after lesion dissection serving as the standard of reference. RESULTS： In hypo- and isodense lesions PET/CT proved more accurate in defining the position of the interventional device when compared with CT alone. The mean RMS for CT and PET/CT differed significantly in isodense and hypodense lesions. No significant difference was found for hyperdense lesions. CONCLUSION： Combined FDG-PET/CT imaging provides more accurate information than CT alone concerning the needle position in FDG-PET positive liver lesions. Therefore combined PET/CT might be potentially beneficial not only for localization of an interventional device, but may also be beneficial for guidance in interventional liver procedures.

关键词： Liver biopsy Radiofrequency ablation Combined PET/CT ex-vivo study Image guided interventions

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection

引用

World Journal of Gastroenterology 2015年第20期21卷 6384-6390页

作者： Sophie Schneitler Patric Krpil Jasmin Riemer gerald antoch Wolfram Trudo Knoefel Dieter Hussinger Dirk Graf Department of Gastroenterology Hepatology and Infectious DiseasesMedical FacultyUniversity Düsseldorf Department of Diagnostic and Interventional Radiology Medical FacultyUniversity Düsseldorf Department of Pathology Medical FacultyUniversity Düsseldorf Department of General Surgery Medical FacultyUniversity Düsseldorf

Patients with metastasized carcinoma of the pancreas have a very poor prognosis, and long-term survival cannot be expected. This case report describes two patients with an initial diagnosis of metastatic pancreatic cancer, both with hepatic metastases and one with an additional peritoneal carcinomatosis. Initially, both patients were treated intravenously with the FOLFIRINOX chemotherapy regimen, consisting of 5-FU, folinic acid, irinotecan and oxaliplatin. Surprisingly, the FOLFIRINOX treatment resulted in complete resolution of the hepatic metastases in both patients, with no lesions detectable by computed tomography scan. Furthermore, treatment response included decreased diameter of the primary tumor in the tail of the pancreas and disappearance of the additional peritoneal carcinomatosis. Both patients were discussed by our multidisciplinary tumor board, which recommended surgical resections of the carcinoma. The R0 resection of the primary tumor was successful in both cases and, interestingly, the resected tissues showed no evidence of the hepatic metastases intraoperatively. In the first case, the patient received a postoperative 6-mo course of adjuvant chemotherapy with gemcitabine. In the second case, the patient continued to receive the FOLFIRINOX regimen for an additional 6 mo postoperatively. At 12 mo after the operation, a nonresectable retroperitoneal lymph node metastasis was detected in the first patient, whereas the second patient remained in complete remission at the time of this report(5 mo after the adjuvant therapy was discontinued). This case report is the first of its kind to describe two cases of hepatic metastatic pancreatic carcinoma that were resectable following treatment with FOLFIRINOX. Further studies are required to examine the role of FOLFIRINOX as a neoadjuvant treatment option in subgroups of patients with initially metastasized pancreatic carcinoma.

关键词： FOLFIRINOX Neoadjuvant treatment ofpancreatic neoplasms Chemotherapy Metastaticpancreatic neoplasm Curative operation

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

肿瘤18F-FDG PET/MRI全身显像专家共识(德国)

引用

中华核医学与分子影像杂志 2020年第9期40卷 549-555页

作者：王洋洋杨光杰(译) 王振光(审校) Lale Umutlu Thomas Beyer Johannes Stefan Grueneisen Christoph Rischpler Harald H Quick Veit-Haibach Patrick Matthias Eiber Sandra Purz gerald antoch Sergios Gatidis Konstantin Nikolaou Jürgen FSchaefer IvoRausch Herrmann Ken K.Herrmann B.J.Krause S.O.Schoenberg L.Umutlu F.Anton G.antoch M.Hacker M.Luster S.Neumann D.Vorwerk 青岛大学附属医院核医学科PET/CT中心 266100 Department of Diagnostic and Interventional Radiology and Neuroradiology University-Hospital EssenGermany QIMP Group Centre for Medical Imaging and Biomedical EngineeringMedical University of ViennaAustria Department of Nuclear Medicine University-Hospital EssenGermany High-Field-and Hybrid-MR-Imaging University-Hospital EssenGermany Joint Department of Medical Imaging University of TorontoCanada Department of Nuclear Medicine Klinikum rechts der IsarTechnical University of MunichGermany Department of Nuclear Medicine University of LeipzigGermany Department of Diagnostic and Interventional Radiology University DüsseldorfMedical FacultyDüsseldorfGermany Department of Diagnostic and Interventional Radiology University-Hospital TübingenGermany Department of Nuclear Medicine University Medical Center RostockGermany Department of Clinical Radiology and Nuclear Medicine University Medical Center MannheimGermany Deutsche Röntgengesellschaft BerlinGermany Division of Nuclear Medicine Department of Biomedical Imaging and Image-guided TherapyMedical University ViennaAustria Department of Nuclear Medicine University Hospital MarburgGermany Department of Radiology Klinikum IngolstadtGermany

PET/MRI一体机在2006年被首次提出可应用于临床;2010年,首台临床型PET/MRI一体机诞生。在20世纪早期,PET/CT和SPECT/CT一体机的广泛应用体现了融合显像的优势,为PET/MRI一体机的产生奠定了基础。目前,全球大约有150台全身PET/MRI一体机... 详细信息

PET/MRI一体机在2006年被首次提出可应用于临床;2010年,首台临床型PET/MRI一体机诞生。在20世纪早期,PET/CT和SPECT/CT一体机的广泛应用体现了融合显像的优势,为PET/MRI一体机的产生奠定了基础。目前,全球大约有150台全身PET/MRI一体机投入了临床应用,其中肿瘤显像是PET/MRI的主要应用领域之一。迄今为止,尽管PET/MRI临床应用在增加,但标准化的PET/MRI扫描方案还很少。因此,有必要制定患者检查和多中心研究都可遵循的标准化且一致性好的显像方案。该文总结了18F-脱氧葡萄糖(FDG)PET/MRI全身显像的患者就诊、检查准备、工作流程、显像方案以及报告书写等主要方面的专家共识,由长期使用PET、MRI和较早使用PET/MRI的相关资深专家制定。

关键词： PET/MRI 肿瘤全身显像专家共识

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：